Carvey P[au] - Search Results

Year	Number of Results
1979	1
1980	1
1981	1
1982	3
1983	2
1984	1
1985	1
1986	4
1987	2
1988	3
1989	2
1990	4
1991	4
1992	1
1993	4
1994	2
1995	2
1996	8
1997	3
1998	8
1999	8
2000	5
2001	6
2002	5
2003	1
2004	3
2005	4
2006	3
2007	3
2008	3
2009	5
2011	3
2012	2
2013	1
2014	3
2022	0

1

The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.

Carvey PM, Hendey B, Monahan AJ. Carvey PM, et al. J Neurochem. 2009 Oct;111(2):291-314. doi: 10.1111/j.1471-4159.2009.06319.x. Epub 2009 Jul 31. J Neurochem. 2009. PMID: 19659460 Free PMC article. Review.

2

Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.

Desai BS, Monahan AJ, Carvey PM, Hendey B. Desai BS, et al. Among authors: carvey pm. Cell Transplant. 2007;16(3):285-99. doi: 10.3727/000000007783464731. Cell Transplant. 2007. PMID: 17503739 Free article. Review.

3

Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis.

Monahan AJ, Warren M, Carvey PM. Monahan AJ, et al. Among authors: carvey pm. Cell Transplant. 2008;17(4):363-72. Cell Transplant. 2008. PMID: 18522239 Review.

4

Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis.

Carvey PM, Punati A, Newman MB. Carvey PM, et al. Cell Transplant. 2006;15(3):239-50. doi: 10.3727/000000006783981990. Cell Transplant. 2006. PMID: 16719059 Free article. Review.

5

The role of the serotonin system in animal models of myoclonus.

Goetz CG, Carvey PM, Pappert EJ, Vu TQ, Leurgans SE. Goetz CG, et al. Among authors: carvey pm. Adv Neurol. 2002;89:244-8. Adv Neurol. 2002. PMID: 11968451 Review. No abstract available.

6

Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease.

Carvey PM, Chang Q, Lipton JW, Ling Z. Carvey PM, et al. Front Biosci. 2003 Sep 1;8:s826-37. doi: 10.2741/1158. Front Biosci. 2003. PMID: 12957870 Review.

7

Drug-induced myoclonus.

Klawans HL, Carvey PM, Tanner CM, Goetz CG. Klawans HL, et al. Among authors: carvey pm. Adv Neurol. 1986;43:251-64. Adv Neurol. 1986. PMID: 3484854 No abstract available.

8

Alterations in striatal neurotrophic activity induced by dopaminergic drugs.

Carvey PM, Ptak LR, Lin D, Lo ES, Buhrfiend CM, Drucker GE, Fields JZ. Carvey PM, et al. Pharmacol Biochem Behav. 1993 Sep;46(1):195-204. doi: 10.1016/0091-3057(93)90340-y. Pharmacol Biochem Behav. 1993. PMID: 7902982 Review.

9

The stability of carbidopa in solution.

Pappert EJ, Lipton JW, Goetz CG, Ling ZD, Stebbins GT, Carvey PM. Pappert EJ, et al. Among authors: carvey pm. Mov Disord. 1997 Jul;12(4):608-10. doi: 10.1002/mds.870120422. Mov Disord. 1997. PMID: 9251084 No abstract available.

10

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.

Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS, Snyder J, Zhu YG, Ling ZD. Carvey PM, et al. Eur J Neurosci. 2005 Sep;22(5):1158-68. doi: 10.1111/j.1460-9568.2005.04281.x. Eur J Neurosci. 2005. PMID: 16176358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results